Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 45 results.
User Information
Export Records
  1. 1.   GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity
  2. Heitzeneder, Sabine; Bosse, Kristopher R.; Zhu, Zhongyu; Zhelev, Doncho; Majzner, Robbie G.; Radosevich, Molly T.; Dhingra, Shaurya; Sotillo, Elena; Buongervino, Samantha; Pascual-Pasto, Guillem; Garrigan, Emily; Xu, Peng; Huang, Jing; Salzer, Benjamin; Delaidelli, Alberto; Raman, Swetha; Cui, Hong; Martinez, Benjamin; Bornheimer, Scott J.; Sahaf, Bita; Alag, Anya; Fetahu, Irfete S.; Hasselblatt, Martin; Parker, Kevin R.; Anbunathan, Hima; Hwang, Jennifer; Huang, Min; Sakamoto, Kathleen; Lacayo, Norman J.; Klysz, Dorota D.; Theruvath, Johanna; Vilches-Moure, Jose G.; Satpathy, Ansuman T.; Chang, Howard Y.; Lehner, Manfred; Taschner-Mandl, Sabine; Julien, Jean-Phillipe; Sorensen, Poul H.; Dimitrov, Dimiter S.; Maris, John M.; Mackall, Crystal L.
  3. Cancer Cell. 2022, Jan 10; 40(1): 53-+.
  1. 2.   Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins
  2. Tewary,Poonam; Brooks, Alan D.; Xu, Ya-Ming; Wijeratne, E. M. Kithsiri; Babyak, Ashley L.; Back, Timothy C.; Chari,Raj; Evans,Christine; Henrich,Curtis; Meyer,Thomas; Edmondson,Elijah; de Aquino, Maria T. Prudente; Kanagasabai, Thanigaivelan; Shanker, Anil; Gunatilaka, A. A. Leslie; Sayers, Thomas J.
  3. Cancer Research. 2021, Jun 15; 81(12): 3374-3386.
  1. 3.   Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model
  2. Yamamoto, Jun; Murata, Takuya; Sugisawa, Norihiko; Higuchi, Takashi; Tashiro, Yoshihiko; Nishino, Hiroto; Inubushi, Sachiko; Sun, Y U; Lim, Hyein; Miyake, Kentaro; Shimoya, Koichiro; Nomura, Tsunehisa; Kurebayashi, Junichi; Tanino, Hirokazu; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2475-2479.
  1. 4.   A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib
  2. Yamamoto, Jun; Murata, Takuya; Tashiro, Yoshihiko; Higuchi, Takashi; Sugisawa, Norihiko; Nishino, Hiroto; Inubushi, Sachiko; Sun, Y U; Lim, Hyein; Miyake, Kentaro; Hongo, Atsushi; Nomura, Tsunehisa; Saitoh, Wataru; Moriya, Takuya; Tanino, Hirokazu; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2509-2514.
  1. 5.   Recombinant Methioninase Combined With Tumor-targeting Salmonella typhimurium A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated Liposarcoma
  2. Igarashi, Kentaro; Kawaguchi, Kei; Zhao, Ming; Han, Qinghong; Tan, Yuying; Kiyuna, Tasuku; Miyake, Kentaro; Higuchi, Takashi; Nelson, Scott D; Dry, Sarah M; Li, Yunfeng; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2515-2523.
  1. 6.   Retrospective score tests versus prospective score tests for genetic association with case-control data
  2. Liu, Yukun; Li, Pengfei; Song,Lei; Yu, Kai; Qin, Jing
  3. Biometrics. 2020, Apr 10;
  1. 7.   Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Igarashi, Kentaro; Kawaguchi, Kei; Kiyuna, Tasuku; Miyake, Kentaro; Higuchi, Takashi; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Cancer genomics & proteomics. 2020, Jul-Aug; 17(4): 351-358.
  1. 8.   Oral Recombinant Methioninase, Combined With Oral Caffeine and Injected Cisplatinum, Overcome Cisplatinum-Resistance and Regresses Patient-derived Orthotopic Xenograft Model of Osteosarcoma
  2. Higuchi, Takashi; Oshiro, Hiromichi; Miyake, Kentaro; Sugisawa, Norihiko; Han, Qinghong; Tan, Yuying; Park, Junho; Zhang, Zhiying; Razmjooei, Sahar; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Bouvet, Michael; Chawla, Sant P; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Anticancer research. 2019, Sep; 39(9): 4653-4657.
  1. 9.   Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse Model
  2. Higuchi, Takashi; Sugisawa, Norihiko; Miyake, Kentaro; Oshiro, Hiromichi; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Kline,Zoey; Belt,Paige; Chawla, Sant P; Bouvet, Michael; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Anticancer research. 2019, Sep; 39(9): 4781-4786.
  1. 10.   Oral Recombinant Methioninase Combined with Caffeine and Doxorubicin Induced Regression of a Doxorubicin-resistant Synovial Sarcoma in a PDOX Mouse Model
  2. Higuchi, Takashi; Kawaguchi, Kei; Miyake, Kentaro; Han, Qinghong; Tan, Yuying; Oshiro, Hiromichi; Sugisawa, Norihiko; Zhang, Zhiying; Razmjooei, Sahar; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Chawla, Sant P; Singh, Arun S; Eilber, Frederick C; Singh, Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Anticancer research. 2018, Oct; 38(10): 5639-5644.
  1. 11.   Multiple-response regression analysis links magnetic resonance imaging features to de-regulated protein expression and pathway activity in lower grade glioma.
  2. Lehrer, Michael; Bhadra, Anindya; Ravikumar, Visweswaran; Chen, James Y; Wintermark, Max; Hwang, Scott N; Holder, Chad A; Huang, Erich P; Fevrier-Sullivan, Brenda; Freymann, John; Rao, Arvind
  3. Oncoscience. 2017, Jun 23; 4(5-6): 57-66.
  1. 12.   Does genetic introgression improve female reproductive performance? A test on the endangered Florida panther
  2. Hostetler, J. A.; Onorato, D. P.; Bolker, B. M.; Johnson, W. E.; O'Brien, S. J.; Jansen, D.; Oli, M. K.
  3. Oecologia. 2012, Jan; 168(1): 289-300.
  1. 13.   Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
  2. Muranski, P.; Borman, Z. A.; Kerkar, S. P.; Klebanoff, C. A.; Ji, Y.; Sanchez-Perez, L.; Sukumar, M.; Reger, R. N.; Yu, Z. Y.; Kern, S. J.; Roychoudhuri, R.; Ferreyra, G. A.; Shen, W.; Durum, S. K.; Feigenbaum, L.; Palmer, D. C.; Antony, P. A.; Chan, C. C.; Laurence, A.; Danner, R. L.; Gattinoni, L.; Restifol, N. P.
  3. Immunity. 2011, Dec; 35(6): 972-985.
  1. 14.   An efficient stochastic search for Bayesian variable selection with high-dimensional correlated predictors
  2. Kwon, D.; Landi, M. T.; Vannucci, M.; Issaq, H. J.; Prieto, D.; Pfeiffer, R. M.
  3. Computational Statistics & Data Analysis. 2011, Oct; 55(10): 2807-2818.
  1. 15.   Transduction of SIV-Specific TCR Genes into Rhesus Macaque CD8(+) T Cells Conveys the Ability to Suppress SIV Replication
  2. Barsov, E. V.; Trivett, M. T.; Minang, J. T.; Sun, H. S.; Ohlen, C.; Ott, D. E.
  3. Plos One. 2011, Aug; 6(8): 9.
  1. 16.   Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-x(L)
  2. Mayeenuddin, L. H.; Yu, Y.; Kang, Z.; Helman, L. J.; Cao, L.
  3. Oncogene. 2010, Dec; 29(48): 6367-6377.
  1. 17.   Comparison of Nine Programs Predicting pK(a) Values of Pharmaceutical Substances
  2. Liao, C. Z.; Nicklaus, M. C.
  3. Journal of Chemical Information and Modeling. 2009, Dec; 49(12): 2801-2812.
  1. 18.   Antigen Presented by Tumors In vivo Determines the Nature of CD8(+) T-Cell Cytotoxicity
  2. Shanker, A.; Brooks, A. D.; Jacobsen, K. M.; Wine, J. W.; Wiltrout, R. H.; Yagita, H.; Sayers, T. J.
  3. Cancer Research. 2009 69(16): 6615-6623.
  1. 19.   An inducible and reversible mouse genetic rescue system
  2. Zeng, H. K.; Horie, K.; Madisen, L.; Pavlova, M. N.; Gragerova, G.; Rohde, A. D.; Schimpf, B. A.; Liang, Y. Q.; Ojala, E.; Kramer, F.; Roth, P.; Slobodskaya, O.; Dolka, I.; Southon, E. A.; Tessarollo, L.; Bornfeldt, K. E.; Gragerov, A.; Pavlakis, G.
  3. Plos Genetics. 2008 4(5): 1-13.
  1. 20.   Sensitizing tumor cells to immune-mediated cytotoxicity
  2. Shanker, A.; Sayers, T.
  3. Immune-Mediated Diseases: From Theory to Therapy. 2007; 601 : 163-171.
  1. 21.   Using mutual information to measure the impact of multiple genetic factors on AIDS
  2. Nelson, G. W.; O'Brien, S. J.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2006, Jul; 42(3): 347-354.
  1. 22.   Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma
  2. Khan, T.; Hixon, J. A.; Stauffer, J. K.; Lincoln, E.; Back, T. C.; Brenner, J.; Lockett, S.; Nagashima, K.; Powell, D.; Wigginton, J. M.
  3. Journal of the National Cancer Institute. 2006, FEB 1; 98(3): 190-202.
  1. 23.   Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumors
  2. Stauffer, J. K.; Khan, T.; Salcedo, R.; Hixon, J. A.; Lincoln, E.; Back, T. C.; Wigginton, J. M.
  3. Journal of Immunotherapy. 2006, MAR-APR; 29(2): 151-164.
  1. 24.   Application of the granzyme B ELISPOT assay for monitoring cancer vaccine trials
  2. Shaftr-Weaver, K.; Rosenberg, S.; Strobl, S.; Alvord, W. G.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2006, May-Jun; 29(3): 328-335.
  1. 25.   Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
  2. Rothman, N.; Skibola, C. F.; Wang, S. S.; Morgan, G.; Lon, Q.; Smith, M. T.; Spinelli, J. J.; Willett, E.; De Sanjose, S.; Cocco, P.; Berndt, S. I.; Brennan, P.; Brooks-Wilson, A.; Wacholder, S.; Becker, N.; Hartge, P.; Zheng, T. Z.; Roman, E.; Holly, E. A.; Boffetta, P.; Armstrong, B.; Cozen, W.; Linet, M.; Bosch, F. X.; Ennas, M. G.; Holford, T. R.; Gallagher, R. P.; Rollinson, S.; Bracci, P. M.; Cerhan, J. R.; Whitby, D.; Moore, P. S.; Leaderer, B.; Lai, A.; Spink, C.; Davis, S.; Bosch, R.; Scarpa, A.; Zhang, Y. W.; Severson, R. K.; Yeager, M.; Chanock, S.; Nieters, A.
  3. Lancet Oncology. 2006, JAN; 7(1): 27-38.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel